Non-viral methods for ex vivo cell & gene therapy: is the future non-viral?
The BioInsights Podcast
Chapters
1:51
What non-viral methods are used in the space, and do you see their use evolving?
4:20
What are the advantages and disadvantages of utilizing non-viral technology for ex vivo cell therapy?
8:07
How can the challenge of transfecting cell types using non-viral means be overcome?
9:50
What non-viral gene transfer technology does Lonza offer?
12:11
What advantages does an electroporation-based method offer?
15:57
Is electroporation-based technology scalable to meet the needs of the industry?
17:54
What non-viral technologies are being used in clinical or commercial applications based on ex vivo modifications?
19:01
What are your predictions for the future of this space?
More Info
The BioInsights Podcast
Non-viral methods for ex vivo cell & gene therapy: is the future non-viral?
May 31, 2023 Season 2 Episode 5
Valeria Annibaldi and Andrea Toell

Non-viral methods for ex vivo cell & gene therapy: is the future non-viral? In this episode, Valeria Annibaldi and Andrea Toell discuss the types and benefits of non-viral methods for ex vivo cell and gene therapy in addition to the readiness of electroporation-based technologies for use in GMP manufacturing.

To read this interview and access lots more content, visit the Cell and Gene Therapy Insights website